These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. Ofer-Shiber S; Molad Y Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601 [TBL] [Abstract][Full Text] [Related]
23. [Clinical and analytical manifestations of primary antiphospholipid antibody syndrome]. Camps García MT; Gutiérrez Rueda A; Guil García M; Perelló-González Moreno I; García Portales R; Belmonte López A; de Rámon Garrido E An Med Interna; 1993 Dec; 10(12):576-82. PubMed ID: 8049321 [TBL] [Abstract][Full Text] [Related]
24. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort. Djokovic A; Stojanovich L; Stanisavljevic N; Djokic S; Filipovic B; Matic P; Milanovic M; Apostolovic S; Saponjski J Clin Rheumatol; 2022 May; 41(5):1447-1455. PubMed ID: 35018582 [TBL] [Abstract][Full Text] [Related]
25. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W; Matthias T; Scharrer I Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [TBL] [Abstract][Full Text] [Related]
26. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633 [TBL] [Abstract][Full Text] [Related]
27. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. Hudson M; Herr AL; Rauch J; Neville C; Chang E; Ibrahim R; Séguin C; Kassis J; Busque L; Fortin PR J Rheumatol; 2003 Nov; 30(11):2385-91. PubMed ID: 14677182 [TBL] [Abstract][Full Text] [Related]
28. [Antiphospholipid antibodies syndrome: follow-up of patients with a high antiphospholipid antibodies titer]. Urfer C; Pichler WJ; Helbling A Schweiz Med Wochenschr; 1996 Dec; 126(49):2136-40. PubMed ID: 8999502 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404 [TBL] [Abstract][Full Text] [Related]
30. Survival in primary antiphospholipid syndrome. A single-centre cohort study. Ames PR; Merashli M; Chis Ster I; D'Andrea G; Iannaccone L; Marottoli V; Margaglione M; Brancaccio V Thromb Haemost; 2016 Jun; 115(6):1200-8. PubMed ID: 26864875 [TBL] [Abstract][Full Text] [Related]
31. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]. Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898 [TBL] [Abstract][Full Text] [Related]
32. [Clinico-immunological aspects of antiphospholipid syndrome]. Reshetniak TM; Alekberova ZS; Aleksandrova EN Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468 [TBL] [Abstract][Full Text] [Related]
33. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study. Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381 [TBL] [Abstract][Full Text] [Related]
34. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome. da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539 [TBL] [Abstract][Full Text] [Related]
35. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
36. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875 [TBL] [Abstract][Full Text] [Related]
37. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978 [TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid syndrome: critical analysis of the diagnostic path. Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982 [TBL] [Abstract][Full Text] [Related]
39. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
40. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study). Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D; Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]